Multiprofessional management of metabolic syndrome in patients using antipsychotics

the clinical pharmacist's contribution

Abstract

Objective: To report the clinical experience of the pharmacist in the follow-up of psychiatric patients at a reference hospital in Ceará, highlighting the integration of the pharmaceutical consulting room with the psychiatry outpatient clinic and the role of the multiprofessional team in identifying and managing Drug-Related Problems (DRPs) and comorbidities associated with the use of atypical antipsychotics. Case/Experience Report: The practice took place in a public mental health hospital in Ceará, integrating the pharmaceutical consulting room with the psychiatry outpatient clinic. The pharmacist provided qualified listening and systematic pharmacotherapy review, focusing on monitoring metabolic changes (hypertension, dyslipidemia, and glycemic alterations), frequently associated with the use of second-generation antipsychotics. Routine blood pressure and capillary blood glucose measurements, as well as laboratory test analysis, were adopted. Pharmaceutical interventions, including adjustments to antihypertensive and antidiabetic therapies and the introduction of statins, were discussed and implemented in collaboration with the medical team. Digital tools (Google Sheets, electronic health records) were incorporated to systematize longitudinal follow-up and enable rescheduling for the evaluation of clinical goals. Discussion: The experience demonstrates that the inclusion of the pharmacist in psychiatric services reinforces integral care and the early detection of comorbidities. Pharmaceutical follow-up, regulated by CFF Resolution No. 515/2013, legitimizes this role in metabolic monitoring. Multiprofessional integration and the use of digital resources were crucial for the systematization of care and the effectiveness of interventions.